Pan troglodytes (chimpanzee): 461669
Help
Entry
461669 CDS
T01005
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X2
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
ptr
Pan troglodytes (chimpanzee)
Pathway
ptr01524
Platinum drug resistance
ptr04010
MAPK signaling pathway
ptr04115
p53 signaling pathway
ptr04148
Efferocytosis
ptr04210
Apoptosis
ptr04215
Apoptosis - multiple species
ptr04623
Cytosolic DNA-sensing pathway
ptr04650
Natural killer cell mediated cytotoxicity
ptr04657
IL-17 signaling pathway
ptr04668
TNF signaling pathway
ptr04726
Serotonergic synapse
ptr04932
Non-alcoholic fatty liver disease
ptr04933
AGE-RAGE signaling pathway in diabetic complications
ptr04936
Alcoholic liver disease
ptr05010
Alzheimer disease
ptr05012
Parkinson disease
ptr05014
Amyotrophic lateral sclerosis
ptr05016
Huntington disease
ptr05020
Prion disease
ptr05022
Pathways of neurodegeneration - multiple diseases
ptr05132
Salmonella infection
ptr05133
Pertussis
ptr05134
Legionellosis
ptr05145
Toxoplasmosis
ptr05146
Amoebiasis
ptr05152
Tuberculosis
ptr05160
Hepatitis C
ptr05161
Hepatitis B
ptr05162
Measles
ptr05163
Human cytomegalovirus infection
ptr05164
Influenza A
ptr05165
Human papillomavirus infection
ptr05167
Kaposi sarcoma-associated herpesvirus infection
ptr05168
Herpes simplex virus 1 infection
ptr05169
Epstein-Barr virus infection
ptr05170
Human immunodeficiency virus 1 infection
ptr05200
Pathways in cancer
ptr05203
Viral carcinogenesis
ptr05205
Proteoglycans in cancer
ptr05206
MicroRNAs in cancer
ptr05210
Colorectal cancer
ptr05222
Small cell lung cancer
ptr05416
Viral myocarditis
ptr05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
ptr00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
461669 (CASP3)
04668 TNF signaling pathway
461669 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
461669 (CASP3)
09143 Cell growth and death
04210 Apoptosis
461669 (CASP3)
04215 Apoptosis - multiple species
461669 (CASP3)
04115 p53 signaling pathway
461669 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
461669 (CASP3)
04650 Natural killer cell mediated cytotoxicity
461669 (CASP3)
04657 IL-17 signaling pathway
461669 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
461669 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
461669 (CASP3)
05206 MicroRNAs in cancer
461669 (CASP3)
05205 Proteoglycans in cancer
461669 (CASP3)
05203 Viral carcinogenesis
461669 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
461669 (CASP3)
05222 Small cell lung cancer
461669 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
461669 (CASP3)
05161 Hepatitis B
461669 (CASP3)
05160 Hepatitis C
461669 (CASP3)
05164 Influenza A
461669 (CASP3)
05162 Measles
461669 (CASP3)
05168 Herpes simplex virus 1 infection
461669 (CASP3)
05163 Human cytomegalovirus infection
461669 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
461669 (CASP3)
05169 Epstein-Barr virus infection
461669 (CASP3)
05165 Human papillomavirus infection
461669 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
461669 (CASP3)
05133 Pertussis
461669 (CASP3)
05134 Legionellosis
461669 (CASP3)
05152 Tuberculosis
461669 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
461669 (CASP3)
05145 Toxoplasmosis
461669 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
461669 (CASP3)
05012 Parkinson disease
461669 (CASP3)
05014 Amyotrophic lateral sclerosis
461669 (CASP3)
05016 Huntington disease
461669 (CASP3)
05020 Prion disease
461669 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
461669 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
461669 (CASP3)
05416 Viral myocarditis
461669 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
461669 (CASP3)
04932 Non-alcoholic fatty liver disease
461669 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
461669 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
461669 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
ptr01002
]
461669 (CASP3)
Enzymes [BR:
ptr01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
461669 (CASP3)
Peptidases and inhibitors [BR:
ptr01002
]
Cysteine peptidases
Family C14: caspase family
461669 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
SICA_beta
Motif
Other DBs
NCBI-GeneID:
461669
NCBI-ProteinID:
XP_016806492
Ensembl:
ENSPTRG00000016640
VGNC:
2081
UniProt:
Q5IS54
A0A663DA81
K7D0A9
LinkDB
All DBs
Position
3:complement(186269277..186291091)
Genome browser
AA seq
277 aa
AA seq
DB search
MENTENSVDSKSIKNLEPKIIHGSQSMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTG
MTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLS
HGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDD
DMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVN
RKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacaccgaaaactcagtggattcaaaatccattaaaaatttggaaccaaagatc
atacatggaagccaatcgatggactctggaatatccctggacaacagttataaaatggat
tatcctgagatgggtttatgtataatcattaataataagaattttcataaaagcactgga
atgacatctcggtctggtacagatgtcgatgcagcaaacctcagggaaacattcagaaac
ttgaaatatgaagtcaggaataaaaatgatcttacacgtgaagaaattgtggaattgatg
cgtgatgtttctaaagaagatcacagcaaaaggagcagttttgtttgtgtgcttctgagc
catggtgaagaaggaataatttttggaacaaatggacctgttgacctgaaaaaaataaca
aactttttcagaggggatcgttgtagaagtctaactggaaaacccaaacttttcattatt
caggcctgccgtggtacagaactggactgtggcattgagacagacagtggtgttgatgat
gacatggcgtgtcataaaataccagtggaggccgacttcttgtatgcatactccacagca
cctggttattattcttggcgaaattcaaaggatggctcctggttcatccagtcgctttgt
gccatgctgaaacagtatgccgacaagcttgaatttatgcacattcttacccgggttaac
cgaaaggtggcaacagaatttgagtccttttcctttgacgctacttttcatgcaaagaaa
cagattccatgtattgtttccatgctcacaaaagaactctatttttatcactaa
DBGET
integrated database retrieval system